Cover Image

ORAL ANTICOAGULANTS IN AMBULATORY AND IN-HOSPITAL TREATMENT OF PATIENTS WITH ATRIAL FIBRILLATION ASSOCIATED WITH HYPERTENSION, ISCHEMIC HEART DISEASE AND CHRONIC HEART FAILURE: DATA FROM HOSPITAL REGISTRY RECVASA-CLINIC

Aim. To estimate the rate of oral anticoagulants (OAC) prescription, continuity of anticoagulant therapy in hospital and ambulatory stages along with treatment adherence in patients with atrial fibrillation (AF) associated with hypertension (HT), ischemic heart disease (IHD) and chronic heart failur...

Full description

Saved in:

Bibliographic Details
Main Authors:	E. V. Stepina (Author), M. M. Loukianov (Author), M. A. Bichurina (Author), E. N. Belova (Author), E. V. Kudryashov (Author), Ju. V. Uzkov (Author), S. A. Boytsov (Author)
Format:	Book
Published:	Столичная издательская компания, 2017-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Therapy with Oral Anticoagulants in Patients with Atrial Fibrillation in Outpatient and Hospital Settings (Data from RECVASA Registries)
by: M. M. Loukianov, et al.
Published: (2019)

PATIENTS WITH ATRIAL FIBRILLATION AND ISCHEMIC HEART DISEASE: HOSPITALIZATION STRUCTURE AND ANTITHROMBOTIC THERAPY (RECVASA AF-KURSK REGISTRY)
by: V. P. Mikhin, et al.
Published: (2017)

THE CONTROL OF INTERNATIONAL NORMALISED RATIO IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH WARFARIN IN OUTPATIENT AND HOSPITAL SETTINGS: DATA FROM RECVASA REGISTRIES
by: M. M. Loukianov, et al.
Published: (2018)

PATIENTS WITH ATRIAL FIBRILLATION IN MULTIDISCIPLINARY HOSPITAL: STRUCTURE OF HOSPITALIZATION, CONCOMITANT CARDIOVASCULAR DISEASES AND DRUG TREATMENT (DATA OF RECVASA AF-TULA REGISTRY)
by: M. N. Valiakhmetov, et al.
Published: (2017)

Patients with Atrial Fibrillation in Clinical Practice: Comorbidity, Drug Treatment and Outcomes (Data from RECVASA Registries)
by: M. M. Loukianov, et al.
Published: (2020)

OUTPATIENT REGISTRY OF CARDIOVASCULAR DISEASES (RECVASA): PROSPECTIVE FOLLOW-UP DATA, ESTIMATION OF RISKS AND OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION
by: M. M. Loukianov, et al.
Published: (2015)

OUTPATIENT REGISTRY OF CARDIOVASCULAR DISEASES (RECVASA): PROSPECTIVE FOLLOW-UP DATA, ESTIMATION OF RISKS AND OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION
by: M. M. Loukianov, et al.
Published: (2015)

Patients with Premature Cardiovascular Diseases in Ambulatory Practice: Demographic Characteristics, Risk Factors and Adherence to the Medical Therapy (Data of RECVASA Registry)
by: E. Yu. Andreenkо, et al.
Published: (2020)

CONCOMITANT CARDIOVASCULAR DISEASES AND ANTIHYPERTENSIVE TREATMENT IN OUTPATIENT PRACTICE (BY THE RECVASA REGISTRY DATA)
by: M. M. Loukianov, et al.
Published: (2016)

DIAGNOSTICS, TREATMENT, ASSOCIATED CARDIOVASCULAR AND CONCOMITANT NON-CARDIAC DISEASES IN PATIENTS WITH DIAGNOSIS OF "ATRIAL FIBRILLATION" IN REAL OUTPATIENT PRACTICE (ACCORDING TO DATA OF REGISTRY OF CARDIOVASCULAR DISEASES, RECVASA)
by: M. M. Loukianov, et al.
Published: (2015)

DIAGNOSTICS, TREATMENT, ASSOCIATED CARDIOVASCULAR AND CONCOMITANT NON-CARDIAC DISEASES IN PATIENTS WITH DIAGNOSIS OF "ATRIAL FIBRILLATION" IN REAL OUTPATIENT PRACTICE (ACCORDING TO DATA OF REGISTRY OF CARDIOVASCULAR DISEASES, RECVASA)
by: M. M. Loukianov, et al.
Published: (2015)

PATIENTS WITH COMBINATION OF CHRONIC HEART FAILURE, HYPERTENSION AND HISTORY OF MYOCARDIAL INFARCTION: CLINICAL AND ANAMNESTIC CHARACTERISTICS, ADMINISTRATION OF ACE INHIBITORS, ANGIOTENSIN RECEPTOR BLOCKERS, -BLOCKERS AND ADHERENCE TO THE DRUG THERAPY (DATA OF OUTPATIENT REGISTRY RECVASA)
by: M. M. Loukianov, et al.
Published: (2017)

Patients with Combination of Cardiovascular Diseases and Type 2 Diabetes in RECVASA and REGION Registries: Multimorbidity, Outcomes and Potential Effect of Dapagliflozin in the Russian Clinical Practice
by: M. M. Loukianov, et al.
Published: (2020)

Combination of Atrial Fibrillation and Coronary Heart Disease in Patients in Clinical Practice: Comorbidities, Pharmacotherapy and Outcomes (Data from the REСVASA Registries)
by: M. M. Loukianov, et al.
Published: (2021)

CONCOMITANT CARDIOVASCULAR DISEASES AND ANTIHYPERTENSIVE TREATMENT IN OUTPATIENT PRACTICE (BY THE RECVASA REGISTRY DATA)
by: M. Loukianov
Published: (2017)

CONCOMITANT CARDIOVASCULAR DISEASES AND ANTIHYPERTENSIVE TREATMENT IN OUTPATIENT PRACTICE (BY THE RECVASA REGISTRY DATA)
by: M. Loukianov
Published: (2017)

DIAGNOSIS AND TREATMENT OF PATIENTS WITH SEVERE HYPERCHOLESTEROLEMIA IN REAL OUTPATIENT PRACTICE (ACCORDING TO THE RECVASA REGISTRY)
by: A. I. Ershova, et al.
Published: (2015)

DIAGNOSIS AND TREATMENT OF PATIENTS WITH SEVERE HYPERCHOLESTEROLEMIA IN REAL OUTPATIENT PRACTICE (ACCORDING TO THE RECVASA REGISTRY)
by: A. I. Ershova, et al.
Published: (2015)

Patients with a Combination of Atrial Fibrillation and Chronic Heart Failure in Clinical Practice: Comorbidities, Drug Treatment and Outcomes
by: M. M. Loukianov, et al.
Published: (2022)

COMBINED ANTIHYPERTENSIVE THERAPY IN REAL CLINICAL PRACTICE. FOCUS ON FIXED COMBINATIONS OF ANTIHYPERTENSIVE DRUGS (According to the Data of Outpatient Registries RECVASA and PROFILE)
by: S. Yu. Martsevich, et al.
Published: (2017)

CLINICAL PRACTICE OF BETA-BLOCKERS USAGE IN PATIENTS WITH CARDIOVASCULAR AND CHRONIC RESPIRATORY DISEASES. DATA OF OUTPATIENT REGISTRIES PROFILE AND RECVASA
by: S. Yu. Martsevich, et al.
Published: (2017)

COMPARATIVE CHARACTERISTICS OF MULTIMORBIDITY, DRUG TREATMENT AND OUTCOMES IN POSTSTROKE PATIENTS WITH ATRIAL FIBRILLATION AND WITH OR WITHOUT HISTORY OF MYOCARDIAL INFARCTION (REGISTRY REGION DATA)
by: E. Yu. Okshina, et al.
Published: (2020)

QUALITY ASSESSMENT OF ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION WITHOUT CONCOMITANT CARDIOVASCULAR DISEASES AS A PART OF OUTPATIENT RECVASA REGISTER
by: A. V. Zagrebelnyy, et al.
Published: (2015)

QUALITY ASSESSMENT OF ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION WITHOUT CONCOMITANT CARDIOVASCULAR DISEASES AS A PART OF OUTPATIENT RECVASA REGISTER
by: A. V. Zagrebelnyy, et al.
Published: (2015)

Atrial Fibrillation and Heart Failure as the Onset of AL-Amyloidosis
by: E. V. Reznik, et al.
Published: (2021)

ATRIAL FIBRILLATION AND ISCHEMIC HEART DISEASE: HOW TO COMBINE ANTIPLATELET AND ANTICOAGULANT THERAPY, DEPENDING ON THE CLINICAL SITUATION?
by: D. A. Napalkov, et al.
Published: (2016)

The Anticoagulation in Patients with Atrial Fibrillation: Rivaroxaban and Warfarin
by: I. Yu. Koroleva, et al.
Published: (2016)

Features of Structural and Functional Changes in the Heart in Elderly Patients with Coronary Heart Disease and Atrial Fibrillation
by: L. I. Folomeeva, et al.
Published: (2020)

Stroke Risk Status, Anticoagulation Treatment, and Quality-of-Life in Chinese Patients with Atrial Fibrillation: China Registry of Atrial Fibrillation (CRAF)
by: Yihong Sun, et al.
Published: (2019)

Comorbid conditions in patients with chronic heart failure (according to the registry of chronic heart failure in the Tyumen region)
by: Anna A. Airapetian, et al.
Published: (2023)

Anticoagulation therapy in atrial fibrillation after intracranial hemorrhage
by: A. S. Gerasimenko, et al.
Published: (2021)

Evaluation of adherence of patients with atrial fibrillation to anticoagulant therapy at the outpatient stage of treatment
by: A. V. Sokolov, et al.
Published: (2021)

AN OUTPATIENT WITH ATRIAL FIBRILLATION: KEY FEATURES. THE FIRST DATA OF REKVAZA FP - YAROSLAVL REGISTER
by: V. V. Yakusevich, et al.
Published: (2015)

AN OUTPATIENT WITH ATRIAL FIBRILLATION: KEY FEATURES. THE FIRST DATA OF REKVAZA FP - YAROSLAVL REGISTER
by: V. V. Yakusevich, et al.
Published: (2015)

EVALUATION OF EFFICACY AND SAFETY OF ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION IN PROSPECTIVE FOLLOW-UP
by: M. V. Khruslov, et al.
Published: (2020)

Overuse of Anticoagulation in Treatment of Atrial Fibrillation Patients in University Hospitals of Tehran
by: Mohammadreza Yasinzadeh, et al.
Published: (2015)

APPROACHES TO THE CHOICE OF ANTICOAGULANT THERAPY IN THE TREATMENT OF PATIENTS WITH COMBINATION OF ATRIAL FIBRILLATION WITH CORONARY HEART DISEASE OR PERIPHERAL ATHEROSCLEROSIS: POTENTIAL OF APIXABAN
by: O. D. Ostroumova, et al.
Published: (2018)

Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Renal Dysfunction
by: Z. D. Kobalava, et al.
Published: (2021)

Cardiovascular Diseases and Drug Treatment in Patients with the History of Cerebral Stroke: Data of the Outpatient Registry REGION
by: M. M. Loukianov, et al.
Published: (2019)

Comparison of the New Oral Anticoagulants and Warfarin in Patients with Atrial Fibrillation and Valvular Heart Disease: Systematic Review and Meta-Analysis
by: Yasmin de Souza Lima Bitar, et al.
Published: (2019)